Related Experiment Video
Updated: Mar 1, 2026
09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
1.5K
Toll-Like Receptor 9 Agonists for Cancer Therapy
Davide Melisi1,2, Melissa Frizziero3, Anna Tamburrino4
1Digestive Molecular Clinical Oncology Research Unit, Department of Medicine, University of Verona, 10, Piazzale L.A. Scuro, 37134 Verona, Italy. davide.melisi@univr.it.
Biomedicines
|May 27, 2017
Summary
Toll-like receptor-9 (TLR-9) agonists show promise in cancer immunotherapy by activating immune responses. While well-tolerated in trials, they haven't yet improved patient survival significantly, requiring further research.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- The immune system plays a crucial role in cancer progression.
- Modulating anti-tumor immunity is a key cancer treatment strategy.
- Toll-like receptors (TLRs), particularly TLR-9, are emerging targets for immunotherapy.
Purpose of the Study:
- To evaluate the efficacy of TLR-9 agonists in cancer treatment.
- To assess the safety and tolerability of TLR-9 agonists in clinical trials.
- To explore the potential of TLR-9 agonists in combination therapies.
Main Methods:
- Development of synthetic CpG oligonucleotides (ODNs) as TLR-9 agonists.
- Preclinical studies in various cancer models.
- Clinical trials involving patients with solid tumors.
Main Results:
- CpG ODNs demonstrated tumor growth suppression in preclinical models, both as monotherapy and in combination.
- TLR-9 agonists exhibited good tolerability and met activity endpoints in early-phase clinical trials.
- Significant impact on patient survival has not yet been demonstrated.
Conclusions:
- TLR-9 agonists represent a promising avenue for cancer immunotherapy.
- Further large-scale prospective studies are necessary to confirm survival benefits.
- Combination strategies require continued investigation to optimize therapeutic outcomes.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:39lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.5K
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K